Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
No insider purchases or sales are on record for Healthier Choices Management Corp. in the period covered. Source: SEC Form 4 filings, as of 2026-10-27.
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$3.0K
four quarters, 2025-01-01 to 2025-12-31
Revenue, TTM HCMC
FY Dec 2025
$3.0K
FY Dec 2024
n/a
FY Dec 2023
$55.7M
FY Dec 2022
$29.3M
FY Dec 2021
$13.3M
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
$0
Sep 2025
$199
Jun 2025
$1.0K
Mar 2025
$1.8K
Dec 2024
$156
Sep 2024
$52
At each fiscal year end
Single quarter
Net margin, TTM
n/a
revenue under $1M, the ratio says nothing
Net margin, TTM HCMC
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
-33.2%
FY Dec 2022
-24.7%
FY Dec 2021
-30.3%
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Single quarter
Free cash flow, TTM
-$2.6M
operating cash flow minus capex, 2025-07-01 to 2026-06-30
Free cash flow, TTM HCMC
FY Dec 2025
-$3.9M
FY Dec 2024
-$3.7M
FY Dec 2023
-$4.9M
FY Dec 2022
n/a
FY Dec 2021
-$3.6M
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
-$1.6M
Sep 2024
$438.3K
At each fiscal year end
Single quarter
Debt to equity
n/a
equity is zero or negative, the ratio has no meaning
Debt to equity HCMC
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
0.53x
FY Dec 2022
0.14x
FY Dec 2021
0.00x
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
-0.50x
TTM operating cash flow over long-term 2024-06-30 (24 months older than the period end) plus current 2024-06-30 (24 months older than the period end)
Cash flow to debt HCMC
FY Dec 2025
-0.78x
FY Dec 2024
-0.73x
FY Dec 2023
-1.33x
FY Dec 2022
-1.33x
FY Dec 2021
-1,031.94x
Jun 2026
-0.50x
Mar 2026
-0.70x
Dec 2025
-0.78x
Sep 2025
-0.94x
Jun 2025
-0.64x
Mar 2025
-0.45x
Dec 2024
-0.73x
Sep 2024
-0.37x
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
n/a
average equity is zero or negative
Return on equity HCMC
FY Dec 2025
n/a
FY Dec 2024
-457.6%
FY Dec 2023
-137.1%
FY Dec 2022
-29.2%
FY Dec 2021
-25.6%
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
-13,318%
Mar 2025
-933.9%
Dec 2024
-457.6%
Sep 2024
-259.8%
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
-234.4%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets HCMC
FY Dec 2025
-380.5%
FY Dec 2024
-71.7%
FY Dec 2023
-42.9%
FY Dec 2022
-16.1%
FY Dec 2021
-17.4%
Jun 2026
-234.4%
Mar 2026
-361.8%
Dec 2025
-380.5%
Sep 2025
-317.4%
Jun 2025
-73.4%
Mar 2025
-72.8%
Dec 2024
-71.7%
Sep 2024
-101.0%
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
n/a
tax provision or pre-tax income not filed for the four quarters
Return on invested capital HCMC
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
n/a
capital employed is zero or negative
Return on capital employed HCMC
FY Dec 2025
n/a
FY Dec 2024
-93.0%
FY Dec 2023
n/a
FY Dec 2022
-22.4%
FY Dec 2021
-24.9%
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
-146.7%
Mar 2025
-115.5%
Dec 2024
-93.0%
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
n/a
trailing loss, a multiple of a loss is not meaningful
P/E, trailing HCMC
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
$56.5M
market value at close 2026-10-23 on 2026-08-19 shares, plus long-term 2024-06-30 (24 months older than the period end) plus current 2024-06-30 (24 months older than the period end), minus cash 2026-06-30
Enterprise value HCMC
FY Dec 2025
$52.0M
FY Dec 2024
$27.9M
FY Dec 2023
$47.4M
FY Dec 2022
$40.9M
FY Dec 2021
$75.4M
Jun 2026
$30.1M
Mar 2026
$9.1M
Dec 2025
$52.0M
Sep 2025
$52.0M
Jun 2025
$52.0M
Mar 2025
$27.9M
Dec 2024
$27.9M
Sep 2024
$50.4M
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
-4.9%
TTM free cash flow over market value at close 2026-10-23
FCF yield HCMC
FY Dec 2025
-8.2%
FY Dec 2024
-15.4%
FY Dec 2023
-10.4%
FY Dec 2022
n/a
FY Dec 2021
-3.5%
Jun 2026
-9.7%
Mar 2026
-67.4%
Dec 2025
-8.2%
Sep 2025
-9.8%
Jun 2025
-6.7%
Mar 2025
-9.6%
Dec 2024
-15.4%
Sep 2024
-3.9%
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
n/a
trailing loss, a multiple of a loss is not meaningful
PEG, trailing HCMC
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-23. Hover or tap a tile for its yearly and quarterly history.Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
HCMC ranks highest on risk and compliance (99th percentile) and growth (97th), and lowest on institutional and government (5th), among Consumer Goods peers.
Financial health
12
Inputs
Debt to equityequity is zero or negative, the ratio has no meaning
Cash flow to debt-0.50x · 12 pct, sector of 96
Growth
97
Inputs
Revenue growth, YoY+494.6% · 97 pct, sector of 145
Backlog growth, YoYno backlog line filed, or no year-earlier backlog
Institutional and government
5
Inputs
Funds adding, latest quarter4 · 5 pct, sector of 123
Congress net buyers, 365dno Congress trades in 365 days
Federal contracts, 180dno federal contracts in 180 days
Lobbying spend, 4 quartersno lobbying filings in the last four quarters
Risk and compliance
100
Inputs
Short interest, % of float+0.0% · 100 pct, sector of 157
Recalls per $1B revenue, 3yrevenue under $50M or not filed, so a count cannot be scaled to size
EPA cases per $1B revenue, 5yrevenue under $50M or not filed, so a count cannot be scaled to size
New text in Risk Factors, latest 10-Kneeds two 10-Ks with a Risk Factors section (not 20-F filers or stubs)
3 not measured: Profitability, Insider conviction, US patents
Profitability needs 2 of 4 inputs, 1 present: average equity is zero or negative; capital employed is zero or negative; tax provision or pre-tax income not filed for the four quarters
Insider conviction needs 1 of 2 inputs, 0 present: no Form 4 purchase or sale (code P or S) in 180 days; no insider trades in 180 days
US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet
4 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
No password to create and no card required. We store your email address, your watchlist and your preferences, nothing else.
PRIVACY & COOKIES
We track filings, not you.
Essential cookies keep you signed in and remember this choice.
Google Analytics 4 and Microsoft Clarity load only if you allow them here; they
count visits and record how pages are used. We run no advertising and never sell
data. Details in the privacy policy. Change this any time
via "Cookie settings" in the footer.